checkAd

     553  0 Kommentare Quidel Receives FDA Clearance for Its Lyra(TM) Molecular PCR Assay for the Detection of Infections From Pyogenic Streptococcus Group A and C or G - Seite 3

    2655ID0414D (04/14)

    Lesen Sie auch

    Quidel Contact:
    Quidel Corporation
    Randy Steward
    Chief Financial Officer
    858.552.7931

    Media and Investors Contact:
    Quidel Corporation
    Ruben Argueta
    858.646.8023
    Email Contact


    Seite 3 von 3

    Verfasst von Marketwired
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Quidel Receives FDA Clearance for Its Lyra(TM) Molecular PCR Assay for the Detection of Infections From Pyogenic Streptococcus Group A and C or G - Seite 3 SAN DIEGO, CA--(Marketwired - Apr 22, 2014) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received clearance, via …